Loading...

MREO MEREO BIOPHARMA GROUP PLC Delisting Actions 8-K Filing

MR B

MR

MEREO BIOPHARMA GROUP PLC

(MREO)

2026 8-K

Director Resignation

Financial Results Announced

Delisting Notification

Clinical Study Results

Q3 Financial Results

Product Expansion

Financial Statements

Financial Results

Clinical Update

License Agreement Update

Q2 Financial Results

Underwriting Agreement

Interim Data from Phase 2/3...

Financial Results Announcement

Extension Agreement with Ru...

Financial Results Announcement

External Links:

On February 17, 2026, Mereo BioPharma Group plc was notified by Nasdaq that its American Depositary Shares (ADSs) failed to maintain the required minimum bid price of $1.00 over the last 30 days, but has until August 17, 2026, to regain compliance.

AI Assistant

MEREO BIOPHARMA GROUP PLC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.